Testing the LEEF-shoe for diabetic foot health
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism, Skin clinical trials.
This study tests a special shoe designed to reduce foot pressure in people with diabetes and nerve damage. It looks at how well the shoe fits and how comfortable it feels to wear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have type 1 or type 2 diabetes
- You are at moderate to high risk for foot ulcers (IWGDF risk 2 or 3)
- You have been prescribed custom-made orthopedic shoes
- You can walk at least 10 meters without stopping
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if special diabetic recovery shoes and an AI-guided exercise program can help people with diabetes who are receiving hyperbaric oxygen therapy. It's designed for those who can walk a little and have only minor toe loss.
This study tests a new shoe designed to help people with foot drop (when you can't lift the front part of your foot). If you have had foot drop for 6 months or more and can walk a short distance, this trial may help you find a better way to walk.
This trial tests a device called the Leia Sensory Prosthesis, which may help people with peripheral neuropathy improve their balance and walking. It compares the active device to a placebo (sham) to see if it reduces falls and improves stability.
This trial tests a mobile app to help prevent foot ulcers in people with diabetes who are at high risk. You will use the app to track your foot health and get advice to keep your feet safe.
This study tests a new device called Feetsee that helps monitor foot health in people with diabetes. It may help catch foot problems early.
This trial tests a new wound covering called NeoThelium FT to help diabetic foot ulcers heal. It is for people whose ulcer has not improved much with standard care and is not infected or too deep.
Hear when a new Diabetic Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.